Overview / Abstract: |
Dry eye disease (DED) is highly prevalent but frequently underdiagnosed and subsequently undertreated. Studies have demonstrated that meibomian gland dysfunction (MGD) is a leading cause of the development and progression of evaporative DED, caused by a deficient tear film lipid layer that leads to increased tear evaporation. New and emerging treatments with novel mechanisms of action are being investigated that manage the signs and symptoms of DED associated with MGD and offer the potential for improved quality of life and greater preservation of vision. In this continuing education monograph, experts in the field review the pathophysiology, burden, and risk factors associated with DED and MGD and assess the efficacy and safety of current and emerging therapies. |
Expiration |
May 30, 2024 |
Discipline(s) |
Optometry / Ophthalmology CE |
Format |
Monograph |
Credits / Hours |
1.00 |
Accreditation |
This continuing education activity is provided by Vindico Medical Education. |
Presenters / Authors / Faculty |
Alice Epitropoulos, Jennifer Loh |
Sponsors / Supporters / Grant Providers |
This activity is supported by an educational grant from Bausch + Lomb. |
Keywords / Search Terms |
Vindico Medical Education Meibomian Gland Dysfunction and Dry Eye Disease, Meibomian Gland Dysfunction, Dry Eye Disease Free CE CME |